The correlation of c-erbB-2 oncoprotein and established prognostic factors in human breast cancer

Anticancer Research

Volumn 20, Issue 6 D, 2000, Pages 5083-5088

  Sutterlin M W ^a   Haller, A ^a   Gassel, A M ^a   Peters, K ^a   Caffier, H ^a   Dietl, J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Breast cancer; C erbB 2 oncoprotein; HER2 neu; Immunohistochemistry; Prognostic factor; Tumor marker

Indexed keywords

ONCOPROTEIN;

ADULT; AGED; BREAST CANCER; CANCER INVASION; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION FUNCTION; EARLY CANCER; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE C ERB; ONCOGENE NEU; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; RECEPTOR, ERBB-2; STATISTICS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034452433     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Growth factors in development, transformation, and tumorigenesis
2. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor
3. Basic science of HER-2/neu: A review
4. The type 1 growth factor receptor family: New ligands and receptors and their role in breast cancer
5. Oncogenic potential of erbB-2 in human mammary epithelial cells
6. Tyrosine kinase receptor with extensive homology, to EGF receptor shares chromosomal location with neu oncogene
7. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
8. Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression
9. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading
10. Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer
11. ERBB2 amplification in breast cancer with high rate of proliferation
12. Human breast cancer: Identification of populations with a high risk of early relapse in relation to both oestrogen receptor status and c-erbB2 overexpression
13. Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up
14. An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma
15. c-erbB-2 expression in benign and malignant breast disease
16. Should HER2 status be routinely measured for all breast cancer patients?
17. Histological grading and prognosis in breast cancer
18. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
19. The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 cases
20. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry
21. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer
22. c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes
23. The long term prognostic significance of c-erbB-2 in primary breast cancer
24. Immunohistochemical expression of c-erbB-2 oncoprotein and EGF-R in pre- and postmenopausal breast cancer
25. Immunohistochemical detection of estrogen receptor in invasive human breast cancer: Correlation with heat shock proteins, pS2 and oncogene products
26. The relationship between c-erbB-2 expression, Sphase fraction and prognosis in breast cancer
27. HER2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer
28. c-erbB-2 overexpression in amplified and non-amplified breast carcinoma samples
29. Detection of HER2 in mammary carcinoma
30. The role of immunohistochemistry and fluorescence in situ hybridization for HER-2/neu in assessing the prognosis of breast cancer